<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Reactivation of fetal <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> synthesis in adulthood can be seen in <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> affecting the erythropoietic system </plain></SENT>
<SENT sid="1" pm="."><plain>The objective of the present study was to evaluate the incidence and prognostic significance of <z:hpo ids='HP_0011904'>increased hemoglobin F</z:hpo> in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="35143">Hemoglobin</z:chebi> F concentrations and Ggamma/Ggamma + A gamma-<z:chebi fb="0" ids="5386">globin</z:chebi> chain ratios were determined in 26 patients with primary <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Median age of the patients was 65 years; <z:hpo ids='HP_0000001'>all</z:hpo> FAB subtypes were included </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0011904'>Increased hemoglobin F</z:hpo> concentration of up to 20% of total <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> (<z:mpath ids='MPATH_458'>normal</z:mpath>: below 2%) was seen in 16 patients; ten patients had <z:mpath ids='MPATH_458'>normal</z:mpath> values </plain></SENT>
<SENT sid="5" pm="."><plain>There was a significant relation between <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> F concentration and the course of disease, e.g., 12 of the 16 patients with elevated <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> F survived at least 1 year after the examination, in contrast to only three of the ten patients with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> F (p &lt; 0.025) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of six patients with <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> F above 5% survived at least 1 year </plain></SENT>
<SENT sid="7" pm="."><plain>There was no significant difference in the <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> F concentration between patients with and without cytogenetic anomalies </plain></SENT>
<SENT sid="8" pm="."><plain>The Ggamma/Ggamma + A gamma-<z:chebi fb="0" ids="5386">globin</z:chebi> chain ratio was slightly elevated in <z:hpo ids='HP_0000001'>all</z:hpo> patients, with a weak correlation to the degree of <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> F elevation </plain></SENT>
<SENT sid="9" pm="."><plain>The values were not of additional prognostic significance </plain></SENT>
<SENT sid="10" pm="."><plain>The data of the present study suggest that the <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> F concentration may be a prognostic parameter in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>; <z:hpo ids='HP_0011904'>increased hemoglobin F</z:hpo> concentration may indicate a better prognosis </plain></SENT>
</text></document>